참고문헌
- Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004). Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat, 83, 77-86. https://doi.org/10.1023/B:BREA.0000010701.08825.2d
- Bowen RL, StebbingJ, Jones LJ (2006). A review of the ethnic differences in breast cancer. Pharmacogenomics, 7, 935-42. https://doi.org/10.2217/14622416.7.6.935
- Ciatto S, Iossa A, Bonardi R, Pacini P. (1990). Male breast carcinoma: review of a multicenter series of 150 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori, 76, 555-8.
- Dauda AM, Misauno MA, Ojo EO. (2011). Histopathological types of breast cancer in Gombe, North Eastern Nigeria: a seven-year review. Afr J Reprod Health, 15, 109-11.
- Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi, GN (2004). Breast carcinoma in men: a population-based study. Cancer, 101, 51-7. https://doi.org/10.1002/cncr.20312
- Gomez-Raposo C, Zambrana Tevar F, Sereno Moyano M (2010). Male breast cancer. Cancer Treat Reviews, 36, 451-75. https://doi.org/10.1016/j.ctrv.2010.02.002
- Grann VR, Troxel AB, Zojwalla NJ, et al (2005). Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer, 103, 2241-51. https://doi.org/10.1002/cncr.21030
- Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. (2012). Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol, 19, 3199-204. https://doi.org/10.1245/s10434-012-2479-z
- Homaei-Shandiz F, Ghavam-Nassiri MR, Sharifi N, et al (2006). Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J, 27, 1810-4.
- Micheli-Pellegrini V. (1975). Letter: More on lid-loading in the management of lagophthalmos. Plast Reconstr Surg, 55, 482. https://doi.org/10.1097/00006534-197555040-00016
- Moradi-Marjaneh M, Homaei-Shandiz F, Shamsian SAA, Eftekhar-Zadeh Mashhadi I (2008). Correlation of HER2/neu over expression, p53 protein accumulation and steroid receptor status with tumor characteristics: an Iranian study of breast cancer patients. Iran J Public Health, 37, 19-28.
- Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
- Mousavi SM, MontazeriA, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. https://doi.org/10.1111/j.1524-4741.2007.00446.x
- Ruddy KJ, Winer EP. (2013). Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol, 24, 1434-43. https://doi.org/10.1093/annonc/mdt025
- Vetto J, Jun SY, Paduch D, et al (1999). Stages at presentation, prognostic factors, and outcome of breast cancer in males. American J Surgery, 177, 379-83. https://doi.org/10.1016/S0002-9610(99)00067-7
- Wisinski KB, GW (2010). Male breast cancer . In W. and W. Harris JR, Lippman ME, Morrow M, Osborne CK Diseases of the Breast, 34thrd edition (4th ed., pp. 775-780). Philadelphia.
- Zygogianni AG, Kyrgias G, Gennatas C, et al (2012). Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches. Asian Pac J Cancer Prev, 13, 15-9. https://doi.org/10.7314/APJCP.2012.13.1.015